Randomized controlled trial of once-per-week intermittent fasting for health improvement: the WONDERFUL trial

Author:

Bartholomew Ciera L1ORCID,Muhlestein Joseph B23,May Heidi T2,Le Viet T24ORCID,Galenko Oxana2,Garrett Kelly Davis56,Brunker Cherie78ORCID,Hopkins Ramona O910,Carlquist John F23,Knowlton Kirk U211ORCID,Anderson Jeffrey L23ORCID,Bailey Bruce W1ORCID,Horne Benjamin D212ORCID

Affiliation:

1. Department of Exercise Sciences, Brigham Young University, Provo, UT, USA

2. Intermountain Medical Center Heart Institute, 5121 S. Cottonwood St., Salt Lake City, UT 84107, USA

3. Cardiology Division, Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA

4. Rocky Mountain University of Health Professions, Provo, UT, USA

5. Neuropsychology, Intermountain Medical Center, Salt Lake City, UT, USA

6. Center for Aging, University of Utah, Salt Lake City, UT, USA

7. Geriatric Medicine, Department of Internal Medicine, Intermountain Medical Center

8. Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA

9. Pulmonary Division, Department of Internal Medicine, Intermountain Medical Center, Salt Lake City, UT, USA

10. Psychology Department and Neuroscience Center, Brigham Young University, Provo, UT, USA

11. Division of Cardiovascular Medicine, Department of Medicine, University of California San Diego, La Jolla, CA, USA

12. Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, CA, USA

Abstract

Abstract Aims Low-density lipoprotein cholesterol (LDL-C) predicts heart disease onset and may be reduced by intermittent fasting. Some studies, though, reported that fasting increased LDL-C; however, no study evaluated LDL-C as the primary endpoint. This randomized controlled trial evaluated the effect of low-frequency intermittent fasting on LDL-C and other biomarkers. Methods and results Adults aged 21–70 years were enrolled who were not taking a statin, had modestly elevated LDL-C, had ≥1 metabolic syndrome feature or type 2 diabetes, and were not taking anti-diabetic medication (N = 103). Water-only 24-h fasting was performed twice weekly for 4 weeks and then once weekly for 22 weeks; controls ate ad libitum. The primary outcome was 26-week LDL-C change score. Secondary outcomes (requiring P ≤ 0.01) were 26-week changes in homeostatic model assessment of insulin resistance (HOMA-IR), Metabolic Syndrome Score (MSS), brain-derived neurotrophic factor (BDNF), and MicroCog general cognitive proficiency index (GCPi). Intermittent fasting (n = 50) and control (n = 53) subjects were, respectively, aged 49.3 ± 12.0 and 47.0 ± 9.8 years, predominantly female (66.0% and 67.9%), and overweight (103 ± 24 and 100 ± 21 kg) and had modest LDL-C elevation (124 ± 19 and 128 ± 20 mg/dL). Drop-outs (n = 12 fasting, n = 20 control) provided an evaluable sample of n = 71 (n = 38 fasting, n = 33 control). Intermittent fasting did not change LDL-C (0.2 ± 16.7 mg/dL) vs. control (2.5 ± 19.4 mg/dL; P = 0.59), but it improved HOMA-IR (−0.75 ± 0.79 vs. −0.10 ± 1.06; P = 0.004) and MSS (−0.34 ± 4.72 vs. 0.31 ± 1.98, P = 0.006). BDNF (P = 0.58), GCPi (P = 0.17), and weight (−1.7 ± 4.7 kg vs. 0.2 ± 3.5 kg, P = 0.06) were unchanged. Conclusions A low-frequency intermittent fasting regimen did not reduce LDL-C or improve cognitive function but significantly reduced both HOMA-IR and MSS. Trial registration  clinicaltrials.gov, NCT02770313.

Funder

Intermountain Research and Medical Foundation

Dell Loy Hansen Heart Foundation

Publisher

Oxford University Press (OUP)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3